“Regional Impact of Prophylaxis With the Monoclonal Antibody Palivizumab on Ospitalizations from Respiratory Syncytial Virus in Infants”. Swiss Medical Weekly 131, no. 1112 (March 24, 2001): 146–151. Accessed February 1, 2026. https://www.smw.ch/index.php/smw/article/view/41.